Literature DB >> 29540855

Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.

Sho Sugawara1,2, Yasutaka Yamada1,2, Takayuki Arai1,2, Atsushi Okato1,2, Tetsuya Idichi3, Mayuko Kato1,2, Keiichi Koshizuka1, Tomohiko Ichikawa2, Naohiko Seki4.   

Abstract

Analyses of microRNA (miRNA) expression signatures obtained by RNA sequencing revealed that some passenger miRNAs (miR-144-5p, miR-145-3p, miR-149-3p, miR-150-3p, and miR-199a-3p) acted as anti-tumor miRNAs in several types of cancer cells. The involvement of passenger strands in the pathogenesis of human cancer is a novel concept. Based on the miRNA signature of bladder cancer (BC) obtained by RNA sequencing, we focused on both strands of the miR-223-duplex (miR-223-5p and miR-223-3p) and investigated their functional significance in BC cells. Ectopic expression of these miRNAs showed that both miR-223-3p (the guide strand) and miR-223-5p (the passenger strand) inhibited cancer cell migration and invasion of BC cells. The role of miR-223-5p (the passenger strand) has not been well studied. Combining gene expression studies and in silico database analyses, we demonstrated the presence of 20 putative target genes that could be regulated by miR-223-5p in BC cells. Among these targets, high expression of five genes (ANLN, INHBA, OIP5, CCNB1, and CDCA2) was significantly associated with poor prognosis of BC patients based on The Cancer Genome Atlas (TCGA) database. Moreover, we showed that a gene (ANLN) encoding a multifunctional actin-binding protein was directly regulated by miR-223-5p in BC cells. Overexpression of ANLN was observed in BC clinical specimens and high expression of ANLN was significantly associated with poor prognosis of BC patients. We suggest that studies of regulatory cancer networks, including the passenger strands of miRNAs, may provide new insights into the pathogenic mechanisms of BC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29540855     DOI: 10.1038/s10038-018-0437-8

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  52 in total

Review 1.  Bladder Cancer: Diagnosis and Treatment.

Authors:  Katharine C DeGeorge; Harry R Holt; Stephanie C Hodges
Journal:  Am Fam Physician       Date:  2017-10-15       Impact factor: 3.292

2.  ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.

Authors:  Chie Suzuki; Yataro Daigo; Nobuhisa Ishikawa; Tatsuya Kato; Satoshi Hayama; Tomoo Ito; Eiju Tsuchiya; Yusuke Nakamura
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

3.  MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.

Authors:  Yaling Tang; Yifeng Wang; Qionghua Chen; Naxuan Qiu; Yan Zhao; Xueye You
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 4.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

Authors:  Sebastien Antoni; Jacques Ferlay; Isabelle Soerjomataram; Ariana Znaor; Ahmedin Jemal; Freddie Bray
Journal:  Eur Urol       Date:  2016-06-28       Impact factor: 20.096

Review 5.  High-Risk Non-Muscle-Invasive Bladder Cancer-Therapy Options During Intravesical BCG Shortage.

Authors:  Rajan Veeratterapillay; Rakesh Heer; Mark I Johnson; Raj Persad; Christian Bach
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

6.  Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.

Authors:  Takayuki Arai; Atsushi Okato; Satoko Kojima; Tetsuya Idichi; Keiichi Koshizuka; Akira Kurozumi; Mayuko Kato; Kazuto Yamazaki; Yasuo Ishida; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Cancer Sci       Date:  2017-08-19       Impact factor: 6.716

7.  Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.

Authors:  Shuxiong Zeng; Xiaowen Yu; Chong Ma; Ruixiang Song; Zhensheng Zhang; Xiaoyuan Zi; Xin Chen; Yang Wang; Yongwei Yu; Junjie Zhao; Rongchao Wei; Yinghao Sun; Chuanliang Xu
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

8.  The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.

Authors:  Toshihiko Itesako; Naohiko Seki; Hirofumi Yoshino; Takeshi Chiyomaru; Takeshi Yamasaki; Hideo Hidaka; Tomokazu Yonezawa; Nijiro Nohata; Takashi Kinoshita; Masayuki Nakagawa; Hideki Enokida
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

9.  Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.

Authors:  Ryosuke Matsushita; Hirofumi Yoshino; Hideki Enokida; Yusuke Goto; Kazutaka Miyamoto; Masaya Yonemori; Satoru Inoguchi; Masayuki Nakagawa; Naohiko Seki
Journal:  Oncotarget       Date:  2016-05-10

10.  The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.

Authors:  Keiichi Yonemori; Naohiko Seki; Tetsuya Idichi; Hiroshi Kurahara; Yusaku Osako; Keiichi Koshizuka; Takayuki Arai; Atsushi Okato; Yoshiaki Kita; Takaaki Arigami; Yuko Mataki; Yuko Kijima; Kosei Maemura; Shoji Natsugoe
Journal:  Oncotarget       Date:  2017-07-26
View more
  21 in total

1.  Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis.

Authors:  Chen Fang; Le Xu; Wei He; Jun Dai; Fukang Sun
Journal:  Cell Cycle       Date:  2019-10-15       Impact factor: 4.534

Review 2.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

3.  Anti-apoptotic Effect of MiR-223-3p Suppressing PIK3C2A in Cardiomyocytes from Myocardial Infarction Rat Through Regulating PI3K/Akt Signaling Pathway.

Authors:  Liu Xiaoyu; Zhang Wei; Zhao Ming; Jia Guowei
Journal:  Cardiovasc Toxicol       Date:  2021-05-17       Impact factor: 3.231

4.  LncRNA SLCO4A1-AS1 modulates colon cancer stem cell properties by binding to miR-150-3p and positively regulating SLCO4A1.

Authors:  Kun Wu; Ting Xu; Xudong Song; Jie Shen; Shutao Zheng; Li Zhang; Guoquan Tao; Baofei Jiang
Journal:  Lab Invest       Date:  2021-05-06       Impact factor: 5.662

5.  Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance.

Authors:  Yinjie Su; Weiping Yang; Ning Jiang; Juanyi Shi; Luping Chen; Guangzheng Zhong; Junming Bi; Wei Dong; Qiong Wang; Chunhui Wang; Tianxin Lin
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

6.  CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.

Authors:  Shouping Wang; Kun Cao; Yuting Liao; Wei Zhang; Jihua Zheng; Xiaocui Li; Mengting Huang; Yonghao Zhong; Xiao Hu; Yanjie Wang
Journal:  Oncogene       Date:  2021-06-08       Impact factor: 9.867

7.  miR-223-5p targeting ERG inhibits prostate cancer cell proliferation and migration.

Authors:  Yongbao Wei; Junming Peng; Shuyun He; Haijian Huang; Le Lin; Qingguo Zhu; Liefu Ye; Tao Li; Xing Zhang; Yunliang Gao; Xiaochun Zheng
Journal:  J Cancer       Date:  2020-05-18       Impact factor: 4.207

8.  Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.

Authors:  Takayuki Arai; Satoko Kojima; Yasutaka Yamada; Sho Sugawara; Mayuko Kato; Kazuto Yamazaki; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Mol Oncol       Date:  2018-12-21       Impact factor: 6.603

9.  Silencing circular RNA UVRAG inhibits bladder cancer growth and metastasis by targeting the microRNA-223/fibroblast growth factor receptor 2 axis.

Authors:  Chen Yang; Siqi Wu; Xiaobo Wu; Xuejian Zhou; Shengming Jin; Haowen Jiang
Journal:  Cancer Sci       Date:  2018-12-07       Impact factor: 6.716

10.  Molecular Pathogenesis of Gene Regulation by the miR-150 Duplex: miR-150-3p Regulates TNS4 in Lung Adenocarcinoma.

Authors:  Shunsuke Misono; Naohiko Seki; Keiko Mizuno; Yasutaka Yamada; Akifumi Uchida; Hiroki Sanada; Shogo Moriya; Naoko Kikkawa; Tomohiro Kumamoto; Takayuki Suetsugu; Hiromasa Inoue
Journal:  Cancers (Basel)       Date:  2019-04-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.